Cytochrome P450 1A1 induction in rat lymphoid tissues following in vivo and in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin requires protein kinase C

Toxicology

Volumn 124, Issue 1, 1997, Pages 39-51

  Stephen, Frank D ^a   Drahushuk, Adam T ^a   Olson, James R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Biomarkers; Cytochrome P450 1A1; Dioxin; Lymphocytes; Protein kinase C

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 ISOENZYME; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; LYMPHOID TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYMOCYTE;

ANIMALS; CYTOCHROME P-450 CYP1A1; ENZYME INDUCTION; LYMPHOID TISSUE; MALE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA;

EID: 0030862389     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00128-5     Document Type: Article

References (58)

1. al-Bayati, Z.A., Wahba, Z.Z, Stohs, S.J., 1988. 2,3,7,8-Tetra-chlorodibenzo-p-dioxin (TCDD)-induced alterations in lipid peroxidation, enzymes, and divalent cations in rat testis. Xenobiotica 18, 1281-1289.
2. 1-450 gene in human mitogen-stimulated lymphocytes. Cancer Res. 46, 2423-2427.
3. Berghard, A., Gradin, K., Pongratz, I., Whitelaw, M., Poellinger, L., 1993. Cross-coupling of signal transduction pathways: The dioxin receptor mediates induction of cytochrome P-450la1 expression via a protein kinase C-dependent mechanism. Mol. Cell. Biol. 13, 677-689.
4. Berry, N., Nishizuka, Y., 1990. Protein kinase C and T cell activation. Eur. J. Immunol. 189, 205-214.
5. Bombick, D.W., Madhukar, B.V., Brewster, D.W., Matsumura, F., 1985. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increase in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig. Biochem. Biophys. Res. Commun. 127, 296-302.
6. Carrier, F., Owens, R.A., Nebert, D.W., Puga, A., 1992. Dioxin-dependent activation of murine Cypla-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12, 1856-1863.
7. Clark, G., Tritscher, A., Bell, D., Lucier, G., 1992. Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs. Environ. Health Perspect. 98, 125-132.
8. Cosma, G.N., Toniolo, P., Currie, D., Pasternack, B.S., Gerte, S.J., 1992. Expression of the CYP1A1 gene in peripheral lymphoyctes as a marker of exposure to creosote in railroad workers. Can. Epidemiol. Biomarkers Prev. 1, 137-142.
9. Crofts, F., Taioli, E., Trachman, J., Cosma, G.N., Currie, D., Toniolo, P., Garte, S.J., 1994. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15, 2961-2963.
10. DePetrillo, R.B., Kurl, R.N., 1993. Stimulation of protein kinase C by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat thymocytes. Toxicol. Lett. 69, 31-36.
11. Drahushuk, A.T., McGarrigle, B.P., Tai, H.-L., Kitareewan, S., Goldstein, J.A., Olson, J.R., 1996. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxic. Appl. Pharm. 140, 393-403.
12. Freedman, H.J., Parker, N.B., Marinello, A.J., Gurtoo, H.J., Minowada, J., 1979. Induction, inhibition and biological properties or aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788. Cancer Res. 39, 4612-4619.
13. Germolec, D.R., Adams, N.S., Luster, M.I., 1995. A comparative assessment of metabolic enzyme levels in macrophage subpopulations in the F334 rat. Biochem. Parmacol. 50, 1495-1504.
14. Germolec, D.R., Henry, E.C., Maronpot, R., Foley, J.F., Adams, N.H., Gasiewicz, T.A., Luster, M.I., 1996. Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzodioxin (TCDD). Toxicol. Appl. Pharm. 137, 57-66.
15. Gerte, S.J., Trachman, J., Crofts, F., Toniolo, P., Buxbaum, J., Bayo, S., Taioli, E., 1996. Distribution of composite CYP1A1 genotypes in Africans, African-Americans and Caucasians. Human Heredity 46, 121-171.
16. Gregorio, C.C., Kubo, R.T., Bankert, R.B., Repasky, E.A., 1992. Translocation of spectrin and protein kinase C to a cytoplasmic aggregate upon lymphocyte activation. Proc. Natl. Acad. Sci. 89, 4947-4951.
17. Holladay, S.D., Lindstrom, P., Blaylock, B.L., Comment, C.E., Germolec, D.R., Heindell, J.J., Luster, M.I., 1991. Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to tetrachlorodibenzo-p-dioxin (TCDD). Teratology 44, 385-393.
18. Ikegwuonu, F.I., Ganem, L.G., Larsen, M.C., Shen, X., Jefcoate, C.R., 1996. The regulation by gender, strain, dose and feeding status of the induction of multiple forms of cytochrome P450 isozymes in rat hepatic microsomes by 2,4,5,2′,4′,5′-hexachlorobiphenyl. Toxicol. Appl. Pharm. 139, 33-41.
19. Israel, D.I., Whitlock, J.P., 1984. Regulation of cytochrome P1-450 gene transcription by 2,3,7,8-tetrachlorodibenzo-p-dioxin in wild-type and variant mouse hepatoma cells. J. Biol. Chem. 259, 5400-5402.
20. Jeong, H.G., Yang, K.-H., 1996. Expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin inducible cytochrome P4501A1 in human splenic lymphocyte cultures. Cancer Lett. 98, 193-198.
21. Kerkvliet, N.I., Braunder, J.A., 1990a. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ. Res. 52, 146-164.
22. Kerkvliet, N.I., Steppan, L.B., Smith, B.B., Youngsberg, J.A., Henderson, M.C., Buhler, D.R., 1990b. Role of the Ah locus in suppression of cytotoxic T lymphocytes (CTL) activity by halogenated aromatic hydrocarbons (PCBs and TCDD): Structure-activity relationships and effects in C57B1/6 mice. Fundam. Appl. Toxicol. 14, 532-541.
23. Kori, R.E., Ratrie, H., 1974. Aryl hydrocarbon hydroxylase induction in human lymphocyte cultures by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Life Sci. 15, 1585-1595.
24. Landi, M.T., Bertazzi, P.A., Clark, G., Lucier, G.W., Garte, S.J., Cosma, G., Shields, P.G., Caporaso, N.E., 1993. Susceptibility markers in normal subjects: A pilot study for the investigation of 2,3,7,8-tetrachlorodibenzo-p-dioxin related diseases. Chemosphere 27, 375-381.
25. Landi, M.T., Bertazzi, P.A., Shields, P.G., Clark, G., Lucier, G.W., Garte, S.J., Cosma, G., Caporase, N.E., 1994. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4, 242-246.
26. Lang, D.S., Becker, S., Devlin, R.B., Koren, H.S., 1996. 2,3,7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral blood lymphocytes. Toxicol. Lett. 88, 317-325.
27. Larsen, M.C., Ikegwuonu, F.I., Brake, P., Jefcoate, C.R., 1994. Phenobarbital-induction of P450 cytochromes in rat liver: Genetic and endocrine control of a common regulatory mechanism. In: Lechner, M.C. (Ed.), Cytochrome P450. Biochemistry, Biophysics and Molecular Biology. Libbey Eurotext, Paris, pp. 121-124.
28. Lorr, N.A., Golemboski, D.R., Clark, G.C., Weigand, G., Rosenthal, G.J., 1992. Distribution and inducibility of a P450I activity in cellular components of the avian immune system. Arch. Toxicol. 60, 560-566.
29. Luster, M.I., Boorman, G.A., Dean, J.H., Harris, M.W., Luebke, R.W., Padarathsingh, M.L., Moore, J.A., 1980. Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Int. J. Pharm. 2, 301-310.
30. Nagayama, J., Kiyohara, C., Masuda, Y., Kuratsune, M., 1985. Genetically mediated induction of aryl hydrocarbon hydroxylase in human lymphoblastoid cells by polychlorinated dibenzofuran isomers and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol. 56, 230-235.
31. Nebert, W., 1987. The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20, 153-174.
32. Newstead, J.L., Giesy, J.P., 1993. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the epidermal growth factor receptor in hepatic plasma membranes of rainbow trout (Oncorhynchus mykiss). Toxicol. Appl. Pharm. 119, 41-51.
33. Okino, S.T., Pendurthi, U.R., Tukey, R.H., 1992. Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cypla-1 and Cypla-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 267, 6991-6998.
34. Oughton, J.A., Pereira, C.B., DeKrey, G., Collier, J.M., Frank, A.A., Kerkvliet, N.I., 1995. Phenotypic analysis of spleen, thymus, and peripheral blood cells in aged C57B1/6 mice following long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 25, 60-69.
35. Poland, A., Bradfleld, C., 1992. A brief review of the Ah locus. Tohoku J. Exp. Med. 168, 83-87.
36. Poland, A., Knutson, J.C., 1982. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
37. Prough, R.A., Burke, M.D., Meyer, R.T., 1978. Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol. 52, 372-377.
38. Raunio, H., Pelkonen, O., 1983. Effect of polycyclic aromatic compounds and phorbol esters on ornithine decarboxylase and aryl hydrocarbon hydroxylase activities in mouse liver. Cancer. Res. 43, 782-786.
39. Reyes, H., Reisz-Porszasz, S., Hankinson, O., 1992. Identification of the Ah receptor nuclear translocator (ARNT) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
40. Safe, S.H., 1986. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol. 26, 371-399.
41. Smialowicz, R.J., Riddle, M.M., Williams, W.C., Diliberto, J.J., 1994. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulation: Differences between mice and rats. Toxicol. Appl. Pharm. 123, 248-256.
42. Smialowicz, R.J., Williams, W.C., Riddle, M.M., 1996. Comparison of the T cell-independent antibody response of mice and rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 32, 293-297.
43. Soon, B.-J., Gelboin, H.V., Park, S.S., Tsokos, G.C., Friedman, F.K., 1985. Monoclonal antibody-directed radioimmunoassay detects cytochrome P-450 in human placenta and lymphocytes. Science 228, 490-492.
44. Stephen, F.D., Olson, J.R., 1997. Role of protein kinase C in TCDD-induced CYP1A1 expression in lymphocytes. Toxi-cologist 36, 218.
45. Thomas, P.T., Hinsdill, R.D., 1979. The effect of perinatal exposure to tetrachlorodibenzo-p-dioxin on the immune response of young mice. Drug Chem Toxicol. 2, 77-98.
46. Thompson, C.L., McCoy, Z., Lambert, J.M., Andries, M.J., Lucier, G.W., 1989. Relationship among benzo-a-pyrene metabolism, benzo-a-pyrene-diolpepoxide: DNA adduct formation and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. Cancer Res. 49, 6503-6511.
47. Van den Berg, M., De Jongh, J., Poiger, H., Olson, J.R., 1994. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit. Rev. Toxicol. 24, 1-74.
48. Vanden Heuvel, J.P., Clark, G.C., Thompson, C.L., McCoy, Z., Miller, C.R., Lucier, G.W., Bell, D.A., 1993. CYP1A1 mRNA levels as a human exposure biomarker: Use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 14, 2003-2006.
49. Vecchi, A., Sironi, M.A., Canegrati, M., Recchia, M., Garattini, S., 1983. Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility to induction of aryl hydrocarbon hydroxylase. Toxicol. Appl. Pharm. 68, 434-441.
50. Vos, J.G., Moore, J.A., 1974. Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int. Arch. Allergy Appl. Immunol. 47, 777-794.
51. Waithe, W.I., Michaud, M., Harper, P.A., Okey, A.B., Anderson, A., 1991. The Ah receptor, cytochrome P450IA1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem. Pharm. 41, 85-92.
52. Weber, T.J., Chapkin, R.S., Davidson, L.A., Ramos, K.S., 1996. Modulation of protein kinase C-related signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits cell cycle dependence. Arch. Biochem. Biophys. 328, 227-232.
53. Weber, T.J., Ou, X., Merchant, M., Wang, X., Safe, S.H., Ramos, K.S., 1994. Biphasic modulation of protein kinase C (PKC) activity by polychlorinated dibenzo-p dioxins (PCDDs) in serum-deprived rat aortic smooth muscle cells. J. Biochem. Toxicol. 9, 113-120.
54. Whitlock, J.P., 1987. The regulation of gene expression by 2,3,7,8-tetrachloro-dibenzo-p-dioxin. Pharmacol. Rev. 39, 147-161.
55. Whitlock, J.P. Jr., 1993. Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6, 754-763.
56. Wolfle, D., Schmutte, C., Marquardt, H., 1993. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on protein kinase C and inositol phosphate metabolism in primary cultures or rat hepatocytes. Carcinogenesis 14, 2283-2287.
57. Wood, S.C., Jeong, H.G., Morris, D.L., Holsapple, M.P., 1993. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsilar lymphocytes. Toxicology 81, 131-143.
58. Zorn, N.E., Russell, D.H., Buckley, A.R., Sauro, M.D., 1995. Alterations in splenic protein kinase C (PKC) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Lett. 78, 93-100.